知镜 Cognispect · 医学文献与研究工作台

Pulmonary Arterial Hypertension Associated With Chronic Mephedrone Use: A Case Report.

Kashoub M, Plunkett M, Nashat H, Dimopoulos K, McCabe C, Harries C, John Wort S, Dargan PI, Price LC.
Pulmonary circulation · 2026-10-01 · PMID 42824527

文献摘要

Mephedrone is a synthetic cathinone with sympathomimetic effects, but has not previously been linked to pulmonary arterial hypertension (PAH). We report a 42-year-old woman with no prior cardiopulmonary disease who presented with severe pre-capillary PAH after a decade of near-daily mephedrone use. Extensive evaluation-including autoimmune, infectious, genetic, and imaging studies-excluded recognised causes of PAH. Following cessation of mephedrone and initiation of dual oral PAH-targeted therapy, she demonstrated substantial initial clinical and haemodynamic improvement; however, the response remained incomplete, necessitating further treatment escalation with selexipag. This appears to be the first reported case of PAH linked to mephedrone use.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。